# Program 1 Phase Y - Post-Gate Remediation Plan and Blocker Resolution Map

Status: documentation-only post-gate remediation planning. Not production approval.

## Purpose

Phase Y converts the Phase X readiness gate findings into a conservative blocker map. It identifies unresolved governance gaps, classifies blockers by severity, defines future evidence needs, records deferred runtime capabilities, and prevents accidental transition into implementation.

Phase Y keeps Program 1 in non-production status.

## Scope

- Convert Phase X gate findings into a blocker map.
- Identify unresolved governance gaps.
- Classify blockers by severity and remediation category.
- Define evidence required before future review.
- Define capabilities that remain explicitly deferred.
- Preserve non-production continuity.

## Non-scope

Phase Y does not add runtime code, tests, helpers, scripts, imports, services, database migrations, API endpoints, UI flows, schedulers, task runners, integrations, clinical write workflows, patient messaging, appointment mutation, workflow enforcement, auth/authz/RBAC runtime behavior, audit logging runtime behavior, approval/clearance/override runtime capability, production-readiness claim, or go-live authorization.

## Safety boundaries

Program 1 remains not cleared for production use, live clinical deployment, real patient data, PHI/PII processing, autonomous diagnosis or treatment, clinical write workflows, patient messaging, appointment status mutation, workflow enforcement, Task engine behavior, Outcome Evidence behavior, runtime auth/authz/RBAC behavior, runtime audit logging behavior, approval/clearance/override capability, or go-live.

## Phase X input summary

Phase X concluded that Program 1 remains blocked from production-readiness claims. It reviewed the phase history through Phase W, confirmed non-production continuity, and preserved all no-go boundaries.

## Blocker inventory

The detailed blocker inventory is recorded in `PROGRAM_1_PHASE_Y1_BLOCKER_INVENTORY.md`.

## Remediation categories

Phase Y uses conservative categories: documentation-only clarification, governance review required, clinical safety review required, privacy/legal review required, security architecture review required, technical design required, runtime implementation deferred, and prohibited until separately approved.

## Blocker resolution map

The blocker resolution map identifies required review, required artifacts, allowed current actions, prohibited current actions, future dependencies, and current decisions. It does not authorize implementation.

## Non-production decision tree

The Phase Y decision tree always ends in non-production unless all required approvals are explicitly present in a future authorized phase. It is documentation-only and does not describe runtime approval or override logic.

## Required evidence before future review

Future review would require formal production approval path, real-data governance approval, PHI/PII processing approval, clinical accountability model, human-in-the-loop responsibility model, security model, privacy model, audit model, authorization model, incident response model, validation evidence model, rollback model, and deployment governance model.

## Deferred runtime capabilities

Auth/authz/RBAC, audit logging, patient messaging, appointment mutation, Task engine, Outcome Evidence, workflow enforcement, clinical write workflows, approval/clearance/override behavior, real-data processing, and production deployment remain deferred, not implemented, not approved, and not partially enabled by Phase Y.

## Explicit non-approval statement

Phase Y is not production approval, real-data approval, PHI/PII processing approval, clinical deployment approval, operational approval, validation approval, or go-live authorization.

## Next-step decision

Recommended next phase: `Program 1 Phase Z - Governance Closure Index and Pre-Implementation Hold Record`.

## Closure statement

Phase Y closes with Program 1 still documentation-only for this module, non-production, blocker-bound, and not cleared for implementation escalation.
